Showing 1 - 20 results of 30 for search 'Jiejie Xu', query time: 0.05s
Refine Results
-
1
Author Correction: EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma by Haiou Liu, Yidong Liu, Weisi Liu, Weijuan Zhang, Jiejie Xu
Published 2021-11-01
Article -
2
Lane Change Trajectory Planning Based on Quadratic Programming in Rainy Weather by Chengzhi Deng, Yubin Qian, Honglei Dong, Jiejie Xu, Wanqiu Wang
Published 2023-09-01
Article -
3
Adaptive MPC-Based Lateral Path-Tracking Control for Automatic Vehicles by Shaobo Yang, Yubin Qian, Wenhao Hu, Jiejie Xu, Hongtao Sun
Published 2024-03-01
Article -
4
-
5
Effect of Laser-Textured Cu Foil with Deep Ablation on Si Anode Performance in Li-Ion Batteries by Jingbo Wang, Li Cao, Songyuan Li, Jiejie Xu, Rongshi Xiao, Ting Huang
Published 2023-09-01
Article -
6
Multiple DSB Resection Activities Redundantly Promote Alternative End Joining-Mediated Class Switch Recombination by Xikui Sun, Xikui Sun, Jingning Bai, Jingning Bai, Jiejie Xu, Jiejie Xu, Xiaoli Xi, Mingyu Gu, Mingyu Gu, Chengming Zhu, Hongman Xue, Chun Chen, Junchao Dong, Junchao Dong, Junchao Dong
Published 2021-11-01
Article -
7
-
8
Prognostic value of EZH2 expression and activity in renal cell carcinoma: a prospective study. by Li Liu, Zhibing Xu, Lei Zhong, Hang Wang, Shuai Jiang, Qilai Long, Jiejie Xu, Jianming Guo
Published 2013-01-01
Article -
9
-
10
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer by Jiejie Xu, Yu Zhu, Zewei Wang, Han Zeng, Zhaopei Liu, Yuan Chang, Le Xu, Kaifeng Jin, Yijia Xu
Published 2022-03-01
Article -
11
-
12
-
13
-
14
Blockade of V‐domain immunoglobulin suppressor of T‐cell activation reprograms tumour‐associated macrophages and improves efficacy of PD‐1 inhibitor in gastric cancer by Yifan Cao, Kuan Yu, Zihao Zhang, Yun Gu, Yichao Gu, Wandi Li, Weijuan Zhang, Zhenbin Shen, Jiejie Xu, Jing Qin
Published 2024-02-01
Article -
15
-
16
-
17
-
18
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer by Jiejie Xu, Yu Zhu, Zewei Wang, Han Zeng, Zhaopei Liu, Yuan Chang, Yiwei Wang, Le Xu, Kaifeng Jin, Fei Shao, Sen Yan
Published 2022-05-01
Article -
19
Targeting myeloid checkpoint Siglec-10 reactivates antitumor immunity and improves anti-programmed cell death 1 efficacy in gastric cancer by Heng Zhang, Chao Lin, Hongyong He, Hao Liu, Ruochen Li, He Li, Jiejie Xu, Fei Shao, Yun Gu, Hanji Fang, Jieti Wang, Kunpeng Lv, Mengyao Sun
Published 2023-11-01
Article -
20
Functional short tandem repeat polymorphism of PTPN11 and susceptibility to hepatocellular carcinoma in Chinese populations. by Xiankun Zhao, Shuxiang Hu, Lu Wang, Qing Zhang, Xiaodan Zhu, Hua Zhao, Chaoqun Wang, Ruiyang Tao, Siping Guo, Jing Wang, Jiejie Xu, Yan He, Yuzhen Gao
Published 2014-01-01
Article